Sorrento Therapeutics (NASDAQ:SRNE) Coverage Initiated by Analysts at StockNews.com
Equities research analysts at StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued to clients and investors on Tuesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Up 25.0 % SRNE opened at $0.00 on Tuesday. Sorrento Therapeutics has a […]
Equities research analysts at StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued to clients and investors on Tuesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Up 25.0 % SRNE opened at $0.00 on Tuesday. Sorrento Therapeutics has a […]
